EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors

Ian Nykaza iD, Yonina R Murciano-Goroff, Antoine Desilets, Guilherme Harada, Michael A Postow, Margaret K Callahan, Chung-Han Lee, Charles M Rudin, David Paul Kelsen, Zsofia K Stadler, Andreas G Wibmer, Jaclyn F Hechtman und 2 weitere

The Oncologist · 08.05.2025 · 30 (5)

DOI: 10.1093/oncolo/oyaf017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 11.05.2025. Verfasst von Ian Nykaza und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Sarcoidosis, Lymphadenopathy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance While new intrathoracic adenopathy in a patient with cancer can represent progression of disease, the differential diagnosis is broad. Sarcoid-like reactions (SLR) remain an underreported source of lymphadenopathy in patients treated with immune checkpoint inhibitors (ICI), with limited reports in patients with cancers other than melanoma.

Objective

To characterize SLRs among patients treated with ICI for advanced solid tumors.

Methods

Data were collected on the clinical, pathologic, and radiographic presentation of patients treated with ICI who developed clinical or imaging findings suggestive of an SLR, including the presence of hilar or mediastinal lymphadenopathy, cutaneous/subcutaneous involvement, and/or worsening of existing sarcoidosis on ICI.

Results

Twelve patients were identified as having experienced an SLR. While 6 patients had melanoma, SLRs were also observed among patients with lung, gynecologic, and genitourinary cancers, including high-grade serous ovarian carcinoma, and an angiomyolipoma. Median time from initiation of ICI to diagnosis of an SLR was 3.4 months (range: 1.8-9.1). All but one patient (92%) were deemed to have had a radiographic response to ICI. Conclusions and relevance Clinicians should maintain the awareness of the possibility of SLRs in patients receiving ICI, particularly in patients whose scans show evidence of “mixed” response, with decreases in certain lesions coupled with new/increasing intrathoracic lymphadenopathy and/or other systemic signs of sarcoid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsSarcoidosisLymphadenopathyHumansFemaleMaleMiddle AgedAgedAdultAged, 80 and overMelanoma

Stichwörter der Autor:innen

immune checkpoint inhibitorsimmunotherapysarcoid-like reactionsarcoidosis

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
  • Department of Medicine, Weill Cornell Medical College, New York, NY 10065, United States.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.

ORCID-Profile: Ian Nykaza, Alexander Drilon

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health
  • Memorial Sloan Kettering Cancer Center

Zitieren

APA

Nykaza, I., Murciano-Goroff, Y. R., Desilets, A., Harada, G., Postow, M. A., Callahan, M. K., Lee, C. H., Rudin, C. M., Kelsen, D. P., Stadler, Z. K., Wibmer, A. G., Hechtman, J. F., Drilon, A., & Friedman, C. F. (2025). Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors. The Oncologist, 30(5). https://doi.org/10.1093/oncolo/oyaf017

Vancouver

Nykaza I, Murciano-Goroff YR, Desilets A, Harada G, Postow MA, Callahan MK, et al. Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors. The Oncologist. 2025;30(5). doi:10.1093/oncolo/oyaf017

BibTeX
@article{Nykaza2025,
  author = {Nykaza, Ian and Murciano-Goroff, Yonina R and Desilets, Antoine and Harada, Guilherme and Postow, Michael A and Callahan, Margaret K and Lee, Chung-Han and Rudin, Charles M and Kelsen, David Paul and Stadler, Zsofia K and Wibmer, Andreas G and Hechtman, Jaclyn F and Drilon, Alexander and Friedman, Claire F},
  title = {Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors},
  journal = {The Oncologist},
  year = {2025},
  volume = {30},
  number = {5},
  doi = {10.1093/oncolo/oyaf017}
}
Kostenlos starten →